GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (OTCPK:IPDQF) » Definitions » Cash Flow from Investing

IPDQF (Impedimed) Cash Flow from Investing : $-1.33 Mil (TTM As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Impedimed Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the six months ended in Dec. 2024, Impedimed spent $0.00 Mil on purchasing property, plant, equipment. It gained $0.00 Mil from selling property, plant, and equipment. It spent $0.00 Mil on purchasing business. It gained $0.00 Mil from selling business. It spent $0.00 Mil on purchasing investments. It gained $0.00 Mil from selling investments. It paid $0.37Mil for net Intangibles purchase and sale. And it paid $0.00 Mil for other investing activities. In all, Impedimed spent $0.37 Mil on investment activities in financial market and operating subsidiaries for the six months ended in Dec. 2024.


Impedimed Cash Flow from Investing Historical Data

The historical data trend for Impedimed's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed Cash Flow from Investing Chart

Impedimed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.49 -1.88 -3.67 -4.06 -2.06

Impedimed Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.81 -2.26 -1.12 -0.95 -0.37

Impedimed Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Impedimed's Cash Flow from Investing for the fiscal year that ended in Jun. 2024 is calculated as:

Impedimed's Cash Flow from Investing for the quarter that ended in Dec. 2024 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Impedimed  (OTCPK:IPDQF) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Impedimed's purchase of property, plant, equipment for the six months ended in Dec. 2024 was $0.00 Mil. It means Impedimed spent $0.00 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Impedimed's sale of property, plant, equipment for the six months ended in Dec. 2024 was $0.00 Mil. It means Impedimed gained $0.00 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Impedimed's purchase of business for the six months ended in Dec. 2024 was $0.00 Mil. It means Impedimed spent $0.00 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Impedimed's sale of business for the six months ended in Dec. 2024 was $0.00 Mil. It means Impedimed gained $0.00 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Impedimed's purchase of investment for the six months ended in Dec. 2024 was $0.00 Mil. It means Impedimed spent {stock_data.stock.currency_symbol}}0.00 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Impedimed's sale of investment for the six months ended in Dec. 2024 was $0.00 Mil. It means Impedimed gained $0.00 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Impedimed's net Intangibles purchase and sale for the six months ended in Dec. 2024 was $-0.37 Mil. It means Impedimed paid $0.37 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Impedimed's cash from discontinued investing activities for the six months ended in Dec. 2024 was 0.00 Mil. It means Impedimed paid $0.00 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Impedimed's cash from other investing activities for the six months ended in Dec. 2024 was $0.00 Mil. It means Impedimed paid $0.00 Mil for other investing activities.


Impedimed Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Impedimed's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Impedimed Business Description

Traded in Other Exchanges
Address
50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.

Impedimed Headlines

From GuruFocus

Q3 2021 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2024 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Ordinary Shareholders Meeting Transcript

By GuruFocus Research 09-14-2024

ImpediMed Ltd Ordinary Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Q1 2023 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Full Year 2022 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2023 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Limited - Special Call Transcript

By GuruFocus Research 02-14-2024

Q2 2024 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 09-14-2024